<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0420</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Urug.Cardiol.]]></abbrev-journal-title>
<issn>1688-0420</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Cardiología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-04202013000400006</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Índice de autores]]></article-title>
</title-group>
<aff id="A">
<institution><![CDATA[,  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<fpage>78</fpage>
<lpage>83</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-04202013000400006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-04202013000400006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-04202013000400006&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[    <basefont size="3"><font face="Verdana" size="2">Índice de autores&nbsp; </font>     <p align="left"><b><font face="Verdana" size="4"> &Iacute;ndice de autores&nbsp; </font></b></p>       <p align="left"><font face="Verdana" size="2"> El n&uacute;mero corresponde al tema libre    <br>       <br>       <br>   </font></p>       <p align="left"><font face="Verdana" size="2"> <b>A&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Abreu R: 23&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Acosta D: 65, 68, 69&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Acosta P: 50, 71&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Aguayo R: 15&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Aguilar MP: 16&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Albertto D: 71&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Albistur J: 9, 50, 60, 61, 71&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Albistur S: 26, 30, 47, 48&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Albornoz H: 52&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Alonso S: 23, 72&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Alonzo J: 24&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Alvarez P: 27, 50, 60, 61, 67&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Amaro M: 68, 69&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Am&eacute;rico C: 32&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Andrade R: 67&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Artucio C: 19, 20, 21, 70&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Azc&uacute;naga M: 27&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>B&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Bachini JP: 26, 30, 43, 47, 48, 65&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Barranco D: 23, 24&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Batista I: 26, 30, 35, 43, 46, 47, 48, 65, 67, 71, 72&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Beneditto V: 23, 24&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Berm&uacute;dez M: 53, 59, 60, 61&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Besada E: 19, 21&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Bia D: 53, 59, 60, 61, 73&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Bigalli D: 18, 34, 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Bilancieri F: 7&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Bouzas P: 74&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Brugnini A: 40&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Brusich D: 54&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Burdiat G: 17, 22, 58&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Burguez S: 23, 24, 46&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>C&nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Calleriza F: 42, 44&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Camejo C: 33&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Cerrutti B: 64&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Conde V: 56&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Conti G: 38&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Corbo C: 32&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Criado N: 58&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Cristar F: 55&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Cura L: 31, 51, 54&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>D&nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Dalto L: 25, 28, 31, 51, 55&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Damian A: 62&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Dayan V: 10, 54, 63&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> del Castillo M: 68, : 69&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Delpiano M: 42, 44&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Di Landro F: 18&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Diangelo S: 4&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> D&iacute;az P: 64&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> D&iacute;az R: 35, 38&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Dieste M: 72&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Dieste T: 23, 46, 72&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Diodato L: 5&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Do Mato G: 42&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Dogliotti A: 4, 5&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Drever M: 10, 63&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Dur&aacute;n A: 26, 30, 43, 64, 65&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Duro I: 64&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>E&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Esmite N: 21, 34, 70&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Estigarribia J: 28&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Estrago V: 32</font></p>     <p align="left"><font face="Verdana" size="2">&nbsp;<b>F</b></font></p>       <p align="left"><font face="Verdana" size="2"> Fajardo A: 32, 33&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Fern&aacute;ndez P: 25, 51&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Ferrando F: 35, 36, 37, 38, 39, 56, 62&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Ferrando R: 35, 36, 37, 62, 73&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Ferreiro A: 25, 28, 31, 51, 55&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Ferrer R: 4, 5&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Figueroa S: 25, 28, 31, 51, 55&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Florio L: 10, 11, 32, 33, 49, 60, 61, 63, 73&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Frache B: 24&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Freire D: 29, 38, 57&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Fronzuti A: 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>G&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Gama A: 27&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Garc&iacute;a V: 53, 60, 61&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Gaye A: 33&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Giambruno M: 69, 68&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Giangrossi M: 74&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> G&oacute;mez A: 27&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Gonz&aacute;lez L: 18, 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Guerra S: 71&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Guti&eacute;rrez F: 18, 34, 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>H&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Heuer A: 18, 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Hominal M: 4, 5, 6, 7&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>J&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Jubany L: 20, 21, 25, 28, 31, 51, 55, 70&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>K&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Kapit&aacute;n M: 62, 73&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Korytnicki D: 19, 20, 21, 70&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Kuster F: 25, 28, 31, 51, 55&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>L&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Lago E: 37&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Langhain M: 73&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Lanz V: 19&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Lanzotti M: 4&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Legnani C: 33&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Lens D: 40&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Lissmann S: 29&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Llanes P2: 6&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Lluberas N: 27, 29, 32, 33, 35, 39, 40, 49, 57&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Lluberas R: 19, 20, 21, 26, 29, 30, 36, 37, 38, 40, 43, 47, 48, 49, 65,  68, 69, 70&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Lluberas S: 21, 70&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> L&oacute;pez J: 6&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> L&oacute;pez P: 52&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Lujambio M: 35, 36, 62, 73&nbsp; </font></p>   <font face="Verdana" size="2">   <b>M&nbsp;</b> </font>     <p align="left"><font face="Verdana" size="2"> Machado F: 74&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Maglione F: 72&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Mallo D: 19, 20, 21, 68, 69, 70&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Marichal A: 54, 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Mart&iacute;nez F: 32, 33, 35, 36, 37, 39, 56&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Martire MV: 3&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Martire V: 1, 2, 3, 8&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Mayol J: 46, 72&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Mazzitelli D: 46&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> MeiriZo A: 7&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Menoyo M: 4&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Mila R: 9, 26, 29, 30, 40, 43, 47, 48, 49, 65, 71&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Miranda N: 29&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Mombelli A: 68, 69&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Mut F: 36&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>N&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Narbondo F: 19, 21, 42, 44&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Negr&iacute;n A: 73&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Niggemeyer A: 52&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>O&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Olalde C: 17, 22, 58&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Ormaechea G: 29, 50, 67&nbsp;&nbsp;</font></p>       <p align="left"><font face="Verdana" size="2"> <b>P&nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Pach&oacute;n J: 56&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Paez L: 29, 57&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Paganini JJ: 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pan M: 73&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Parma G: 10, 11, 32, 33, 49, 63, 57&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pascale A: 73&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pazos A: 32, 33&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pedemonte O: 57&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Peixoto S: 27&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pereyra A: 50&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> P&eacute;rez A: 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pertierra A: 23, 24&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Piedrahita K: 29&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pintos G: 28, 31, 51, 55&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pippo A: 29&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pis Diez E: 1, 2, 3, 8&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Portillo D: 1, 2, 3, 8&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pouso J: 18, 34, 42, 44, 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Pouso M: 19, 20, 21&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Prendez D: 58&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>R&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Ramos F: 29&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Reinoso J: 34, 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Reyes Caorsi W: 42, 44&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Ricca R: 35, 36, 37, 38, 56&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Rivara A: 37, 56, 57&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Rocha A: 25, 28, 31, 51, 55&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Romano J: 71&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Russo D: 56&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Russo N: 18, 34, 66&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>S&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Saccone D: 66&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> S&aacute;nchez A: 52&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Sandoya E: 15, 16, 17, 22, 41, 58&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Sasso D: 25&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Sasso D: 28, 31, 51, 55&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Sciuto J: 57&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Scola R: 46&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Silveira A: 67&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Soca G: 51, 54, 63&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Sommer MJ: 68, 69, 71&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Sorondo M: 64&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Stolovas N: 53&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Straneo P: 10, 54&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Straneo P: 63&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>T&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Techera J: 32&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Tejada J: 17, 22, 58&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Tomasina F: 53&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Tortajada G: 42, 44&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Torterolo A: 57&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Tourn J: 25, 28, 31, 51, 55&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Trias N: 40&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Trujillo P: 9, 26, 30, 38, 40, 43, 47, 48, 49, 64, 65, 71&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Tuzman A: 19, 20, 21, 68, 69, 70&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>U&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Urroz N: 52&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>V&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Vali&ntilde;a R: 46&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Varela G: 42, 44&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> V&aacute;zquez H: 15, 16, 17, 22, 41, 58&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> V&aacute;zquez L: 52&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Vazquez P: 46, 72&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Vidal A: 35, 36, 37, 38, 39, 56&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Vignolo G: 26, 26, 30, 38, 39, 40, 43, 47, 48, 49, 65, 71, 72&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> Vi&ntilde;ole L: 29&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>X&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Xalambri F: 52&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>Z&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Zapata G: 6, 7&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Z&oacute;calo Y: 53, 59, 60, 61, 73&nbsp;</font></p>      <p align="left">&nbsp;</p>        <p align="left"><font face="Verdana" size="2"> &Iacute;ndice de temas libres    <br>   &nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>TEMAS LIBRES PREMIADOS    <br>   &nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> <b>3&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> La aplicaci&oacute;n de planificaci&oacute;n estrat&eacute;gica y de herramientas gen&eacute;ricas  ISO 9001:2008 en el control integral de los factores de riesgo para enfermedad  cardiovascular, determinan una mayor tasa de &eacute;xito a largo plazo.&nbsp;&nbsp;&nbsp;&nbsp;33&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>28&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> &iquest;Es la glicemia intraoperatoria un marcador pron&oacute;stico en cirug&iacute;a card&iacute;aca  en pacientes no diab&eacute;ticos?&nbsp;&nbsp;&nbsp;&nbsp;33&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>40&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Elevados niveles de interfer&oacute;n gamma e interleuquina-10 en el ambiente  intracoronario de pacientes con s&iacute;ndrome coronario agudo con elevaci&oacute;n  del ST.&nbsp;&nbsp;&nbsp;&nbsp;34&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>49&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Evaluaci&oacute;n del tama&ntilde;o de infarto mediante resonancia magn&eacute;tica card&iacute;aca  y su asociaci&oacute;n     <br>   con la circulaci&oacute;n colateral.&nbsp;&nbsp;&nbsp;&nbsp;35&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>52&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Resucitaci&oacute;n con DEA en el Uruguay&nbsp;&nbsp;&nbsp;&nbsp;35&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>60&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Ateromatosis carotidea y caracter&iacute;sticas de tratamiento en pacientes con  disfunci&oacute;n     <br>   sist&oacute;lica de etiolog&iacute;a no isqu&eacute;mica: comparaci&oacute;n con poblaci&oacute;n  control&nbsp;&nbsp;&nbsp;&nbsp;36&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>73&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> El abuso cr&oacute;nico de clorhidrato y pasta base de coca&iacute;na asocia envejecimiento  arterial y aumento del riesgo cardiovascular en j&oacute;venes asintom&aacute;ticos&nbsp;&nbsp;&nbsp;&nbsp;37&nbsp; </font></p>  <font face="Verdana" size="2">      <br>   </font>       <p align="left"><font face="Verdana" size="2"> <b>CARDIOLOG&Iacute;A CL&Iacute;NICA    <br>   &nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> <b>8&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Incidencia y severidad de las alteraciones del metabolismo fosfoc&aacute;lcico  en pacientes hipertensos refractarios de alto riesgo cl&iacute;nico.&nbsp;&nbsp;&nbsp;&nbsp;38&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>15&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Venta de f&aacute;rmacos antihipertensivos e hipertensos tratados en Uruguay&nbsp;&nbsp;&nbsp;&nbsp;38&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>16&nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Prevalencia de la fibrilaci&oacute;n auricular en la poblaci&oacute;n adulta&nbsp;&nbsp;&nbsp;&nbsp;39&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>24&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Primer reporte de caso de endocarditis a <i>Brahamanella catarralis</i> en Uruguay&nbsp;&nbsp;&nbsp;&nbsp;40&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>25&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Endocarditis asociada a dispositivos intracard&iacute;acos&nbsp;&nbsp;&nbsp;&nbsp;40&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>27&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Calidad de la anticoagulaci&oacute;n oral en Policl&iacute;nica de Cardiolog&iacute;a: porcentaje  de tiempo     <br>   en rango terap&eacute;utico. &nbsp;&nbsp;&nbsp;&nbsp;41&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>34&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Calidad de vida relacionada al estado de salud a trav&eacute;s de cuestionarios  SF-36 y DASI     ]]></body>
<body><![CDATA[<br>   en el preoperatorio de CRM&nbsp;&nbsp;&nbsp;&nbsp;41&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>41&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Utilizaci&oacute;n de drogas antihipertensivas en una IAMC de Montevideo&nbsp;&nbsp;&nbsp;&nbsp;42&nbsp; </font></p>  <font face="Verdana" size="2">      <br>   </font>       <p align="left"><font face="Verdana" size="2"> <b>HEMODINAMIA    <br>   &nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> <b>20&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Cambios demogr&aacute;ficos de la poblaci&oacute;n asistida con angioplastia primaria  en una d&eacute;cada&nbsp;&nbsp;&nbsp;&nbsp;43&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>21&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Predictores de &eacute;xito del procedimiento de tromboaspiraci&oacute;n en el IAM&nbsp;&nbsp;&nbsp;&nbsp;43&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>26&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Radioprotecci&oacute;n en procedimientos coronarios intervencionistas: estudio  randomizado comparativo sobre el efecto de la protecci&oacute;n p&eacute;lvica del paciente.  Estudio 4P&nbsp;&nbsp;&nbsp;&nbsp;44&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>30&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Tratamiento de la REstenosis coronaria con bal&oacute;n liberador de PAclitaxel:  seguimiento     <br>   cl&iacute;nico, angiogr&aacute;fico y ultrasonograf&iacute;a intravascular. Estudio  TREPA.&nbsp;&nbsp;&nbsp;&nbsp;44&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>38&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Auditor&iacute;a acad&eacute;mica de las angiograf&iacute;as coronarias sin lesiones epic&aacute;rdicas  significativas     <br>   en un servicio de hemodinamia universitario. Etapa I: an&aacute;lisis  de las indicaciones del procedimiento&nbsp;&nbsp;&nbsp;&nbsp;45&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>43&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> ATC con implante de stent sobre una compleja lesi&oacute;n de TCI. Estrategia  terap&eacute;utica     ]]></body>
<body><![CDATA[<br>   basada en el uso de IVUS.&nbsp;&nbsp;&nbsp;&nbsp;46&nbsp; </font></p>        <p align="left"><font face="Verdana" size="2"> <b>46&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Reporte de un caso de implante percut&aacute;neo valvular a&oacute;rtico por acceso     <br>   no  convencional en paciente con acceso a&oacute;rtico-il&iacute;aco hostil&nbsp;&nbsp;&nbsp;&nbsp;46&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>47&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Reporte de un caso cl&iacute;nico de f&iacute;stula arterio-venosa de arteria mamaria  interna derecha     <br>   a vena mamaria interna derecha secundaria a CRM.&nbsp;&nbsp;&nbsp;&nbsp;47&nbsp; </font></p>  <font face="Verdana" size="2">      <br>   </font>       <p align="left"><font face="Verdana" size="2"> <b>PREVENCI&Oacute;N Y REHABILITACI&Oacute;N    <br>   &nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>2&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Los marcadores vasculares carot&iacute;deos mejoran la predicci&oacute;n de riesgo del  score de Framingham en pacientes asintom&aacute;ticos, a mediano plazo&nbsp;&nbsp;&nbsp;&nbsp;48&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>17&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Mortalidad y sus causas en pacientes coronarios en un programa de     <br>   prevenci&oacute;n  secundaria&nbsp;&nbsp;&nbsp;&nbsp;48&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>22&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Actividad f&iacute;sica en pacientes participantes de un programa de prevenci&oacute;n  secundaria&nbsp;&nbsp;&nbsp;&nbsp;49&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>29&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Efecto del g&eacute;nero en el cumplimiento de los objetivos de prevenci&oacute;n secundaria      <br>   en una poblaci&oacute;n con cardiopat&iacute;a isqu&eacute;mica.&nbsp;&nbsp;&nbsp;&nbsp;50&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>53&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Prevalencia de aterosclerosis subcl&iacute;nica y reclasificaci&oacute;n de riesgo en  trabajadores agropecuarios: an&aacute;lisis de carga/exigencia laboral&nbsp;&nbsp;&nbsp;&nbsp;50&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>58&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Consumo de frutas y verduras en pacientes de un programa de prevenci&oacute;n  secundaria&nbsp;&nbsp;&nbsp;&nbsp;51&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>59&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Reclasificaci&oacute;n del riesgo cardiovascular en una poblaci&oacute;n uruguaya asintom&aacute;tica,      <br>   mediante utilizaci&oacute;n de estudios arteriales no-invasivos.&nbsp;&nbsp;&nbsp;&nbsp;51&nbsp; </font></p>  <font face="Verdana" size="2">      <br>   </font>       <p align="left"><font face="Verdana" size="2"> <b>CARDIOLOG&Iacute;A CL&Iacute;NICA    <br>   &nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>50&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Prevalencia e incidencia de fibrilaci&oacute;n auricular en una poblaci&oacute;n de pacientes      <br>   con disfunci&oacute;n sist&oacute;lica&nbsp;&nbsp;&nbsp;&nbsp;52&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>55&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Evoluci&oacute;n a mediano plazo de pacientes con angor estable y pruebafuncional  positiva     <br>   en ausencia de lesiones coronarias angiogr&aacute;ficamente significativas&nbsp;&nbsp;&nbsp;&nbsp;53&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>57&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Miocardiopat&iacute;a hipertr&oacute;fica: descripci&oacute;n de sus caracter&iacute;sticas y riesgo  de muerte s&uacute;bita     <br>   en una poblaci&oacute;n asistida en policl&iacute;nica especializada.&nbsp;&nbsp;&nbsp;&nbsp;53&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>61&nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Estructura y funci&oacute;n arterial en pacientes con disfunci&oacute;n ventricular izquierda:  diferencias seg&uacute;n etiolog&iacute;a y tiempo de presentaci&oacute;n de la cardiopat&iacute;a  isqu&eacute;mica&nbsp;&nbsp;&nbsp;&nbsp;54&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>67&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Asociaci&oacute;n de ancho de distribuci&oacute;n eritrocitaria y el NT-proBNP en pacientes  portadores     <br>   de insuficiencia cardiaca con disfunci&oacute;n sist&oacute;lica&nbsp;&nbsp;&nbsp;&nbsp;54&nbsp; </font></p>  <font face="Verdana" size="2">      <br>   </font>       <p align="left"><font face="Verdana" size="2"> <b>ELECTROFISIOLOG&Iacute;A    <br>   &nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> <b>4&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Abordaje transeptal &ldquo;simplificado&rdquo; para la ablaci&oacute;n transcat&eacute;ter de sustratos      <br>   arritmog&eacute;nicos auriculares izquierdos. Experiencia de nuestro centro.&nbsp;&nbsp;&nbsp;&nbsp;55&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>42&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> S&iacute;ndrome de Brugada y CDAI. Supervivencia libre de choques apropiados&nbsp;&nbsp;&nbsp;&nbsp;56&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>44&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Ablaci&oacute;n de la fibrilaci&oacute;n auricular (FA) guiada por sistema de mapeo tridimensional  electroanat&oacute;mico. Experiencia inicial&nbsp;&nbsp;&nbsp;&nbsp;56&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>51&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Enfermedad del sistema de conducci&oacute;n como predictor del implante de marcapasos      <br>   definitivo en postoperatorio de sustituci&oacute;n valvular a&oacute;rtica aislada&nbsp;&nbsp;&nbsp;&nbsp;57&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>56&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Bloqueo de rama alternante taquicardia-dependiente en un caso de cardiopat&iacute;a      <br>   isqu&eacute;mica avanzada con severa disfunci&oacute;n sist&oacute;lica&nbsp;&nbsp;&nbsp;&nbsp;57&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>74&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Incidencia temporal de los ritmos desfibrilables y su supervivencia en  el paro cardiaco     <br>   extra hospitalario en Montevideo, Uruguay&nbsp;&nbsp;&nbsp;&nbsp;58&nbsp; </font></p>       <p>&nbsp;</p>       <p align="left"><font face="Verdana" size="2"> <b>S&Iacute;NDROME CORONARIO AGUDO    <br>   &nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> <b>7&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Evoluci&oacute;n contempor&aacute;nea del s&iacute;ndrome de Wellens: impacto de las estrategias      <br>   terap&eacute;uticas actuales.&nbsp;&nbsp;&nbsp;&nbsp;59&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>9&nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Disecci&oacute;n coronaria espont&aacute;nea como causa de SCA&nbsp;&nbsp;&nbsp;&nbsp;59&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>19&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> An&aacute;lisis descriptivo y predictores independientes de revascularizaci&oacute;n  en una poblaci&oacute;n     <br>   de &nbsp;pacientes con S&iacute;ndrome coronario agudo sin elevaci&oacute;n  del ST&nbsp;&nbsp;&nbsp;&nbsp;60&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>23&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Primer reporte de s&iacute;ndrome de Kounis en Uruguay (infarto al&eacute;rgico)&nbsp;&nbsp;&nbsp;&nbsp;61&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>35&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Ausencia de perfusi&oacute;n mioc&aacute;rdica precoz y paradojal en un caso de miocardiopat&iacute;a  de takotsubo. Hallazgos a favor de una disfunci&oacute;n microvascular coronaria  severa asociada     <br>   al estr&eacute;s&nbsp;&nbsp;&nbsp;&nbsp;61&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>39&nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Infarto agudo de miocardio inducido por terazosina en un paciente con cardiopat&iacute;a      <br>   estructural predisponente&nbsp;&nbsp;&nbsp;&nbsp;62&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>68&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Estrategia invasiva precoz en el s&iacute;ndrome coronario agudo sin elevaci&oacute;n  del ST&nbsp;&nbsp;&nbsp;&nbsp;62&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>69&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> &iquest;Cu&aacute;l es el tiempo &oacute;ptimo de hospitalizaci&oacute;n en s&iacute;ndromes coronarios agudos      <br>   con sobreelevaci&oacute;n del ST Killip y Kimbal I y II?&nbsp;&nbsp;&nbsp;&nbsp;63&nbsp; </font></p>  <font face="Verdana" size="2">      <br>   </font>       <p align="left"><font face="Verdana" size="2"> <b>CIRUG&Iacute;A    <br>   &nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>5&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Factores preoperatorios determinantes de mortalidad y estad&iacute;a prolongada  en pacientes octogenarios sometidos a cirug&iacute;a de reemplazo valvular a&oacute;rtico  por estenosis valvular&nbsp;&nbsp;&nbsp;&nbsp;64&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>18&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Supervivencia en los mayores de 75 a&ntilde;os que aceptan o rechazan la cirug&iacute;a  de revascularizaci&oacute;n mioc&aacute;rdica&nbsp;&nbsp;&nbsp;&nbsp;64&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>31&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> La cirug&iacute;a de revascularizaci&oacute;n mioc&aacute;rdica utilizando las dos arterias  mamarias internas esqueletizadas es segura en pacientes con diabetes mellitus&nbsp;&nbsp;&nbsp;&nbsp;65&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>54&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Revascularizaci&oacute;n mioc&aacute;rdica con ambas arterias mamarias internas esqueletizadas.  Experiencia inicial de un centro universitario de cirug&iacute;a card&iacute;aca&nbsp;&nbsp;&nbsp;&nbsp;65&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>66&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Cirug&iacute;a mini invasiva para la sustituci&oacute;n valvular a&oacute;rtica&nbsp;&nbsp;&nbsp;&nbsp;66&nbsp; </font></p>  <font face="Verdana" size="2">      ]]></body>
<body><![CDATA[<br>   </font>       <p align="left"><font face="Verdana" size="2"> <b>HEMODINAMIA    <br>   &nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> <b>48&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Tratamiento paliativo de la estenosis valvular a&oacute;rtica severa en una serie  de pacientes     <br>   cr&iacute;ticos y de alto riesgo quir&uacute;rgico: valvuloplastia a&oacute;rtica  percut&aacute;nea con bal&oacute;n&nbsp;&nbsp;&nbsp;&nbsp;67&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>64&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Angioplastia coronaria en pacientes trasplantados card&iacute;acos&nbsp;&nbsp;&nbsp;&nbsp;67&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>65&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Registro IVUS. Impacto de la ultrasonograf&iacute;a intracoronaria en un servicio  de cardiolog&iacute;a intervencionista. Experiencia inicial&nbsp;&nbsp;&nbsp;&nbsp;68&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>70&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Revascularizaci&oacute;n secundaria en pacientes con cirug&iacute;a de revascularizaci&oacute;n  mioc&aacute;rdica     <br>   previa e indicaci&oacute;n de CACG diagn&oacute;stica&nbsp;&nbsp;&nbsp;&nbsp;68&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>71&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Propuesta de par&aacute;metros objetivos de evaluaci&oacute;n de la extensi&oacute;n y severidad  de la enfermedad coronaria basados en el score Syntax&nbsp;&nbsp;&nbsp;&nbsp;69&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>72&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Neoateromatosis coronaria: una nueva causa de infarto agudo de miocardio&nbsp;&nbsp;&nbsp;&nbsp;70&nbsp; </font></p>  <font face="Verdana" size="2">      <br>   </font>       <p align="left"><font face="Verdana" size="2"> <b>IM&Aacute;GENES    <br>   &nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>1&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Concordancia entre los estudios de perfusi&oacute;n mioc&aacute;rdica con dipiridamol  y test de doble f&aacute;rmaco combinando dipiridamol con adenosina en bajas dosis.&nbsp;&nbsp;&nbsp;&nbsp;70&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>6&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Significado cl&iacute;nico de estudios de perfusi&oacute;n mioc&aacute;rdica normal por SPECT  con electrocardiograma de estr&eacute;s positivo&nbsp;&nbsp;&nbsp;&nbsp;71&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>10&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Dimensiones y valores del complejo a&oacute;rtico en poblaci&oacute;n sana uruguaya&nbsp;&nbsp;&nbsp;&nbsp;72&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>11&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Factibilidad y reproducibilidad intra e interobservador de strain longitudinal  global por     <br>   m&eacute;todo &ldquo;vector velocity imaging&rdquo; en una poblaci&oacute;n adulta&nbsp;&nbsp;&nbsp;&nbsp;72&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>32&nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Variabilidad y reproducibilidad de medidas por ecocardiograf&iacute;a transtor&aacute;cica  es adecuada     <br>   en la vida real de un laboratorio de ecocardiograf&iacute;a&nbsp;&nbsp;&nbsp;&nbsp;73&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>33&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Ateromatosis a&oacute;rtica potencialmente embol&iacute;gena: topograf&iacute;a y valor diagn&oacute;stico  del ecocardiograma transtor&aacute;cico&nbsp;&nbsp;&nbsp;&nbsp;74&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>36&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Efectos de la isquemia mioc&aacute;rdica sobre la disincron&iacute;a mec&aacute;nica intraventricular  izquierda     <br>   en pacientes con trastornos de la conducci&oacute;n intraventricular  y funci&oacute;n contr&aacute;ctil     <br>   conservada&nbsp;&nbsp;&nbsp;&nbsp;74&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>37&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Potencial impacto de la isquemia mioc&aacute;rdica severa sobre la disincron&iacute;a  mec&aacute;nica del VI     ]]></body>
<body><![CDATA[<br>   en presencia de BCRD avanzado&nbsp;&nbsp;&nbsp;&nbsp;75&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>62&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> El supradesnivel del segmento ST en aVR se asocia a mayor riesgo isqu&eacute;mico  en el     <br>   SPECT de perfusi&oacute;n mioc&aacute;rdica&nbsp;&nbsp;&nbsp;&nbsp;76&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2"> <b>63&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> Ser familiar de pacientes con v&aacute;lvula a&oacute;rtica bic&uacute;spide no representa un  riesgo adicional     <br>   en el di&aacute;metro de la aorta ascendente&nbsp;&nbsp;&nbsp;&nbsp;76&nbsp; </font></p>          ]]></body>
</article>
